Literature DB >> 14171266

HYBRIDS DERIVED FROM THE VIRUSES OF ALASTRIM AND RABBIT POX.

H S BEDSON, K R DUMBELL.   

Abstract

Entities:  

Keywords:  CHICK EMBRYO; HYBRIDIZATION; MICE; POXVIRUS; RABBITS; SMALLPOX VIRUS; VIRUS CULTIVATION

Mesh:

Year:  1964        PMID: 14171266      PMCID: PMC2134607          DOI: 10.1017/s0022172400039875

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


× No keyword cloud information.
  9 in total

1.  THE USE OF CEILING TEMPERATURE AND REACTIVATION IN THE ISOLATION OF POX VIRUS HYBRIDS.

Authors:  K R DUMBELL; H S BEDSON
Journal:  J Hyg (Lond)       Date:  1964-06

2.  HYBRIDS DERIVED FROM THE VIRUSES OF VARIOLA MAJOR AND COWPOX.

Authors:  H S BEDSON; K R DUMBELL
Journal:  J Hyg (Lond)       Date:  1964-06

3.  Genetic studies with mammalian poxviruses. III. White (u) mutants of rabbitpox virus.

Authors:  A GEMMELL; F FENNER
Journal:  Virology       Date:  1960-05       Impact factor: 3.616

4.  The reactivation of poxviruses. II. The range of reactivating viruses.

Authors:  F FENNER; G M WOODROOFE
Journal:  Virology       Date:  1960-05       Impact factor: 3.616

5.  Studies with poxviruses by an improved plaque technique.

Authors:  J S PORTERFIELD; A C ALLISON
Journal:  Virology       Date:  1960-02       Impact factor: 3.616

6.  A plaque technique for the titration of vaccinia virus in chick embryo cells and some features of vaccinial infection in this system.

Authors:  R POSTLETHWAITE
Journal:  Virology       Date:  1960-04       Impact factor: 3.616

7.  The biological characters of several strains of vaccinia, cowpox and rabbitpox viruses.

Authors:  F FENNER
Journal:  Virology       Date:  1958-06       Impact factor: 3.616

8.  Production of Plaques in Monolayer Tissue Cultures by Single Particles of an Animal Virus.

Authors:  R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1952-08       Impact factor: 11.205

9.  The specific amino acid requirements of a human carcinoma cell (Stain HeLa) in tissue culture.

Authors:  H EAGLE
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

  9 in total
  11 in total

1.  THE USE OF CEILING TEMPERATURE AND REACTIVATION IN THE ISOLATION OF POX VIRUS HYBRIDS.

Authors:  K R DUMBELL; H S BEDSON
Journal:  J Hyg (Lond)       Date:  1964-06

2.  HYBRIDS DERIVED FROM THE VIRUSES OF VARIOLA MAJOR AND COWPOX.

Authors:  H S BEDSON; K R DUMBELL
Journal:  J Hyg (Lond)       Date:  1964-06

3.  Laboratory studies on a strain of Asian influenza virus used as a living vaccine: (A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines).

Authors:  D Hobson; E A Gould; H I Flockton
Journal:  J Hyg (Lond)       Date:  1967-06

4.  Enzyme studies for the characterization of some orthopoxvirus isolates.

Authors:  H S Bedson
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

5.  An African swine fever virus gene with homology to DNA ligases.

Authors:  J M Hammond; S M Kerr; G L Smith; L K Dixon
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

Review 6.  Vaccinia virus: a suitable vehicle for recombinant vaccines?

Authors:  C Kaplan
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Genome scale patterns of recombination between coinfecting vaccinia viruses.

Authors:  Li Qin; David H Evans
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  A poxvirus antigen associated with pathogenicity for rabbits.

Authors:  C J Rondle; K R Dumbell
Journal:  J Hyg (Lond)       Date:  1982-12

9.  Vaccinia virus particles mix inefficiently, and in a way that would restrict viral recombination, in coinfected cells.

Authors:  Y-C James Lin; D H Evans
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

10.  Identification of nucleotide-level changes impacting gene content and genome evolution in orthopoxviruses.

Authors:  Eneida L Hatcher; Robert Curtis Hendrickson; Elliot J Lefkowitz
Journal:  J Virol       Date:  2014-09-17       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.